Alexion Pharmaceuticals is seeking a Senior Manager of Tax to perform tax technical research and provide technical support for topics relating to tax accounting (ASC 740) and effective tax rate forecasting and scenario modeling. This position is based in our New Haven office and will report to the Tax Controller. This position will be responsible for providing research on various areas of tax accounting (ASC 740), forecasting and scenario modeling of the long-term effective tax rate, technical review of various tax calculations (federal, international and partnership), drafting technical memorandums to support tax positions, and managing various projects as they arise. The Senior Manager of Tax will interface with core finance functions including accounting, business development, legal, treasury, and other leaders across the global organization.
Essential Duties and Responsibilities
Forecast and maintain a dynamic model of the long-term effective tax rate based on internal income projections.
Model effective tax rate implications of proposed domestic and international tax laws, potential tax planning initiatives, and other various one-time transactions.
Assist in the preparation of the tax accounting (ASC 740) implications related to tax planning and other one-time transactions for incorporation in Alexion's consolidated financial statements.
Assist in the adoption of new accounting standards and their impact on deferred taxes.
Assist in the preparation and/or review of various aspects of the tax provision on a quarterly basis.
Provide technical analysis in all areas of tax (Sub C, Sub K, and International), with a focus on the international tax aspects of the Tax Cuts and Jobs Act and tax accounting considerations under ASC 740, as well as other areas with domestic and global tax consequences to Alexion.
Assist with tax purchase accounting associated with M&A activity.
Draft tax accounting research memorandums supporting the proper tax accounting treatment of material transactions.
Review and assist with complex aspects of the U.S. income tax return.
Manage other various tax technical projects as they arise.
BS/BA in Accounting or Finance, CPA, and a Masters in Taxation is preferred.
8+ years of public accounting and/or industry experience, with a preference to Big 4 firms.
Significant tax accounting (ASC 740), partnership tax, and international taxation experience.
Knowledge of the pharmaceutical industry is a plus.
Strong interpersonal skills and communication skills to interact with all levels of an organization.
Must have excellent oral and written communication skills and experience with writing technical memorandums.
Must have strong analytical and technical skills.
Ability to manage and lead both employees and/or outside consultants.
Strong issue/opportunity recognition skills which will directly materially impact the long term corporate strategic direction, growth, and earnings of the company.
Ability to manage and lead both projects and processes on a "one off" and continuing basis.
New Haven, CT, United States
Some opportunities happen only once in a lifetime - like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition, the company is developing two late-stage therapies, a second complement inhibitor and a copper-binding agent for Wilson disease. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders. Alexion has been named to the Forbes list of the World's Most Innovative Companies seven years in a row and is headquartered in Boston, Massachusetts' Innovation District. The company also has offices around the globe and serves patients in more than 50 countries.
Alexion's aspiration is to be the most rewarding place to work, where people are empowered to make a difference and where diversity of backgrounds and ideas is encouraged. We are looking for talented individuals who share our passion and commitment to change the lives of patients with rare diseases. We hope you will consider joining our team. Further information about Alexion can be found at: www.alexion.com.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.
Alexion Pharmaceuticals, Inc.